Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( August )
Competency-based interviewing: Selling your skillset
Drawing on your previous triumphs and failures can help you prove you're up to the job. But preparation is the key to success.(more)
Welcome to the real world
Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement
The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
PharmafocusNews Register for New Alert
News for June 2008
Previous Months: July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Relief as pharma industry secures 'pro-innovation' UK pricing deal
New deal seems to satisfy both pharma and the UK government..(more)

 PPRS reaction
Small-medium sized pharma and biotech..(more)

 NICE budget to be 'significantly increased'
Watchdog chairman says more money needed for new appraisals..(more)

 Darzi review must present a 'clear vision' of reform
Ministers advised to explain what NHS reforms are meant to achieve..(more)

 Incentives lacking for NHS changes
King's Fund warns of significant barriers to shifting care closer to home..(more)

 Latest news from Datamonitor
Inhaler devices are still a major hurdle in asthma and COPD treatment..(more)

 NHS urged to tackle health inequalities
Local profiles show a mixed picture of England's health..(more)

 Chandler Chicco unveils market access unit
Brandtechtonics Europe will operate as a specialist consultancy..(more)

 Patient groups unite to block DTC information from pharma
Warning issued about European Commission proposals..(more)

 Actimis could breath new life into Boehringer respiratory franchise
Novel approach to acquisition could be worth $515m..(more)

 Better palliative care needed for cancer sufferers
National audit concludes not enough progress made..(more)

 GSK wins UK cancer vaccine contract
Sanofi-Pasteur MSD loses out in two-horse race..(more)

 Ranbaxy to have exclusive Lipitor generic launch
Lucrative settlement reached with Pfizer..(more)

 Government and pharma strike new drug price deal
ABPI hails 'outline agreement' a victory for patients..(more)

 Government to review co-payment rules
Patients could be allowed to contribute to cost of NHS treatment..(more)

 Quintiles and Parexel battle for ClinPhone
Parexel makes £91m offer for UK clinical trial software company..(more)

 Restylane TV campaign a first for 'cosmaceuticals'
Q-Med looks to consolidate dermal filler's market-leading position..(more)

 Latest news from Datamonitor
'Conservative' pharmaceutical industry slow to take advantage of online marketing opportunities..(more)

 Daiichi Sankyo acquires Ranbaxy
Deal with Indian generics firm could cost Daiichi up to $4.6 billion..(more)

 Public needs help to be healthy, Kings Fund
Think tank calls for environments where healthier choices are easier to make..(more)

 Private executives to run NHS trusts
Trusts with poor safety and clinical records to be publicly identified..(more)

 Januvia study shows hypoglycaemia benefit
Results show lower risk of side effect common to oral diabetes drugs..(more)

 GSK's Tyverb granted conditional licence in EU
Drug cleared for launch but regulator requires more data..(more)

 Novartis to restrict distribution
Pharma company selects AAH and UniChem as sole distributors..(more)

 Doctors 'scaremongering' over polyclinics
Health secretary accuses BMA of siding with the Conservatives..(more)

 Latest news from Datamonitor
Pharmacovigilance solutions: essential for the future of healthcare..(more)

 Think tank questions polyclinic plans
King's Fund says there's no evidence reform will improve patient care..(more)

 Data boost for Avastin
Study shows benefits in metastatic breast cancer..(more)

 Erbitux set for first line treatment of colorectal cancer
New indication could propel Merck Serono's drug towards blockbuster status..(more)

 Sanofi fights to block generic Plavix in Germany
Pharma company takes legal action to protect its blockbuster..(more)

 Latest news from Datamonitor
Drug distribution restricted as manufacturers attempt to guard supply chain..(more)

 Groundbreaking pharma-NHS collaboration launched in Nottingham
Five companies partner NHS on chronic obstructive pulmonary disorder..(more)

 BMA rails against polyclinics
Doctors say reforms not proven to improve patient services..(more)

 Schering-Plough to exploit new NICE transparency
Company wants access to economic model behind ankylosing spondylitis guidance..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.